Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.
Bridgewater J, Jiao X, Parimi M, Flach C, Stratford J, Kamburov A, Schmitz AA, Zong J, Reeves JA, Keating K, Bruno A, Fellous M, Pereira MB, Bazhenova L. Bridgewater J, et al. Among authors: reeves ja. Cancer Treat Res Commun. 2022;33:100623. doi: 10.1016/j.ctarc.2022.100623. Epub 2022 Aug 23. Cancer Treat Res Commun. 2022. PMID: 36041373 Free article.
Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis.
Italiano A, Nanda S, Briggs A, Garcia-Foncillas J, Lassen U, Vassal G, Kummar S, van Tilburg CM, Hong DS, Laetsch TW, Keating K, Reeves JA, Fellous M, Childs BH, Drilon A, Hyman DM. Italiano A, et al. Among authors: reeves ja. Cancers (Basel). 2020 Nov 4;12(11):3246. doi: 10.3390/cancers12113246. Cancers (Basel). 2020. PMID: 33158040 Free PMC article.
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
Yang JCH, Brose MS, Castro G, Kim ES, Lassen UN, Leyvraz S, Pappo A, López-Ríos F, Reeves JA, Fellous M, Penault-Llorca F, Rudzinski ER, Tabatabai G, Vassal G, Drilon A, Trent J. Yang JCH, et al. Among authors: reeves ja. BMC Cancer. 2022 Jun 7;22(1):625. doi: 10.1186/s12885-022-09687-x. BMC Cancer. 2022. PMID: 35672677 Free PMC article.
Determinants of long-term paramagnetic rim lesion evolution in people with multiple sclerosis.
Reeves JA, Bartnik A, Mohebbi M, Ramanathan M, Bergsland N, Jakimovski D, Wilding GE, Salman F, Schweser F, Weinstock-Guttman B, Hojnacki D, Eckert S, Bagnato F, Dwyer MG, Zivadinov R. Reeves JA, et al. Ann Clin Transl Neurol. 2024 Nov 18. doi: 10.1002/acn3.52253. Online ahead of print. Ann Clin Transl Neurol. 2024. PMID: 39556505 Free article.
Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary.
Fuentes Bayne HE, Kasi PM, Ma L, Hart LL, Wong J, Spigel DR, Schnabel CA, Reeves JA, Halfdanarson TR, Treuner K, Greco FA. Fuentes Bayne HE, et al. Among authors: reeves ja. JCO Precis Oncol. 2024 Sep;8:e2400191. doi: 10.1200/PO.24.00191. JCO Precis Oncol. 2024. PMID: 39231374 Free PMC article.
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer.
Bessudo A, Haseeb AM, Reeves JA, Zhu X, Wong L, Giranda V, Suttner L, Liu F, Chatterjee M, Sharma S. Bessudo A, et al. Among authors: reeves ja. Clin Colorectal Cancer. 2024 Sep;23(3):285-294. doi: 10.1016/j.clcc.2024.05.003. Epub 2024 May 13. Clin Colorectal Cancer. 2024. PMID: 38942693 Free article. Clinical Trial.
56 results